Page 908 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 908

Chapter 56  Conventional and Molecular Cytogenomic Basis of Hematologic Malignancies  791


             TABLE   Chromosomal Translocations in Ph-Negative Myeloproliferative Neoplasms
              56.3
             Chromosomal Abnormality                     Genes Involved                   MPD Entity
             t(9;12)(q34;p13)                            ETV6-ABL                         CML-like, T-ALL
             5q32                                        PDGFRB                           Associated Translocations
             t(1;5)(q25;q32)                             TPM3-PDGFRB                      Atypical MPN
             t(2;5)(p21;q32)                             SPTBN1-PDGFRB                    Atypical MPN
             t(4;5)(q21;q32)                             PRKG2-PDGFRB                     Atypical MPN
             t(5;7)(q32;q11)                             HIP1-PDGFRB                      CMML-like
             t(5;10)(q32;q21)                            CCDC6-PDGFRB                     Ph-negative MPN
             t(5;12)(q32;p13)                            ETV6-PDGFRB                      CEL, CMML
             t(5;12)(q32;p13.3)                          ERC1-PDGFRB                      Atypical MPN
             t(5;14)(q33;q24)                            NIN-PDGFRB                       Atypical MPN
             t(5;14)(q32;q32)                            KIA1509-PDGFRB                   Atypical MPN
             t(5;14)(q32;q32)                            TRIP11-PDGFRB                    AML
             t(5;15)(q23;q15)                            TP53BP1-PDGFRB                   CEL
             t(5;15)(q32;q22)                            TPS3BP1-PDGFRB                   Atypical MPN
             t(5;16)(q32;p13)                            NDE1-PDGFRB                      Atypical MPN
             t(5;17)(q32;p11)                            HCMOGT1-PDGFRB                   Juvenile CMML
             t(5;17)(q32;p11,2)                          MYO18A-PDGFRB                    Atypical MPN
             t(5;17)(q32;p13)                            RABEP1-PDGFRB                    CMML
             t(5;17)(q32;q21)                            COL1A1-PDGFRB                    Atypical MPN
             8p11                                        FGFR1                            Associated Translocations
             t(2;8)(q37;8p11)                            LRRFIP1-FGFR1                    MPN syndrome
             t(6;8)(q27;p11)                             FGFR1OP-FGFR1                    Stem cell MPD
             t(7;8)(q32;p11)                             TRIM24-FGFR1                     MPN
             t(7;8)(q22;p11)                             CUX1-FGFR1                       MPN syndrome
             t(8;9)(p11;q22)                             CEP110-FGFR1                     MPN syndrome
             t(8;11)(p11;p15)                            Nup98-FGFR1                      MPN syndrome
             t(8;12)(p11;p11)                            FGFR10P-FGFR1                    MPN syndrome
             t(8;12)(p11;q12)                            CPSF6-FGFR1                      MPN syndrome
             t(8;13)(p11;q12)                            ZMYM2-FGFR1                      MPN syndrome, leukemia, lymphoma
             t(8;17)(p11;q11)                            MYO18A-FGFR1                     MPN syndrome
             t(8;19)(p11;q13)                            HERVK-FGFR1                      MPN syndrome
             t(8;22)(p11;q11.2)                          BCR-FGFR1                        Lymphoproliferative disorder
             4q12                                        PDGFRA
             del(4)(q12;q12)                             FIP1L1-PDGFRA                    CEL
             t(4;22)(q12;q11.2)                          BCR-FGFR1                        Atypical CML
             4q12                                        KIT                              SM
             9p24                                        JAK2
             t(9;22)(p24;q11.2)                          BCR-JAK2                         CML-like
             t(9;12)(p24;p13)                            JAK2-ETV6                        CML-like
             der(9)t(9;12)(p24;q13)                      JAK-NF-E2                        MDS
             t(8;9)(p22;p24)                             PCM1-JAK2                        CMPD, AL
             der(9;18)t(p13;p11)                         Not reported                     PV, PV→MF
             der(9;18)(p10;q10)                          Not reported                     PV, PV→MF, ET→AML
             der(9)t(1;9)(q12;q12)                       Not reported                     PV, MF
             der(1;7)(q10;p10)                           Not reported                     ET
             t(12)(q21 or q21)                           Not reported                     MF
             AL, Acute leukemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CEL, chronic eosinophilic leukemia; CML, chronic myelogenous leukemia;
             CMML, chronic myelomonocytic leukemia; CMPD, chronic myeloproliferative disorder; ET, essential thrombocytopenia; MF, myelofibrosis; MPD, myeloproliferative
             disorder; MPN, myeloproliferative neoplasm; PV, polycythemia vera; SM, systemic mastocytosis.
   903   904   905   906   907   908   909   910   911   912   913